Preston Dunnmon

1.3k total citations
14 papers, 601 citations indexed

About

Preston Dunnmon is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Preston Dunnmon has authored 14 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Preston Dunnmon's work include Cardiac pacing and defibrillation studies (4 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Cardiac Arrhythmias and Treatments (2 papers). Preston Dunnmon is often cited by papers focused on Cardiac pacing and defibrillation studies (4 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Cardiac Arrhythmias and Treatments (2 papers). Preston Dunnmon collaborates with scholars based in United States, Germany and Canada. Preston Dunnmon's co-authors include S Henderson, Kenneth R. Chien, Robert D. Gerard, A Sen, D Yuan, Robert D. Reynolds, Michael Safdi, Joshua R. Korzenik, Uma Mahadevan and William J. Sandborn and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Preston Dunnmon

14 papers receiving 588 citations

Peers

Countries citing papers authored by Preston Dunnmon

Since Specialization

Citations

This map shows the geographic impact of Preston Dunnmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preston Dunnmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preston Dunnmon more than expected).

Fields of papers citing papers by Preston Dunnmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Preston Dunnmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preston Dunnmon. The network helps show where Preston Dunnmon may publish in the future.

Co-authorship network of co-authors of Preston Dunnmon

This figure shows the co-authorship network connecting the top 25 collaborators of Preston Dunnmon. A scholar is included among the top collaborators of Preston Dunnmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Preston Dunnmon. Preston Dunnmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Pathway for Development and Validation of Multi-domain Endpoints for Amyloid Light Chain (AL) Amyloidosis 2024 ·Therapeutic Innovation & Regulatory Science ·James Signorovitch, Jialü Zhang, David T. Brown, Preston Dunnmon, Liang Xiu, Nicolae Done, (unknown), Yolanda Barbáchano, Isabelle Lousada	1
2	Statistical power considerations in the use of win ratio in cardiovascular outcome trials 2022 ·Contemporary Clinical Trials ·Bang Wang, (unknown), Jialu Zhang, Yoonhee Kim, (unknown), Preston Dunnmon, (unknown), (unknown), (unknown)	6
3	Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium 2017 ·American Heart Journal ·Jonathan P. Piccini, Richard L. Clark, Peter R. Kowey, Suneet Mittal, Preston Dunnmon, Norman Stockbridge, James A. Reiffel, Mintu P. Turakhia, Paul Ziegler, Robert Kleiman, Fraz A. Ismat, Philip T. Sager	6
4	Designing effective drug and device development programs for hospitalized heart failure: A proposal for pretrial registries 2014 ·American Heart Journal ·Stephen J. Greene, Ami N. Shah, Javed Butler, Andrew P. Ambrosy, Stefan D. Anker, Ovidiu Chioncel, Sean P. Collins, Wilfried Dinh, Preston Dunnmon, Gregg C. Fonarow, Carolyn S.P. Lam, Robert J. Mentz, Burkert Pieske, Lothar Roessig, Giuseppe Rosano, Naoki Sato, Muthiah Vaduganathan, Mihai Gheorghiade	23
5	High‐ and Low‐Dose Oral Delayed‐Release Mesalamine in Children With Mild‐to‐Moderately Active Ulcerative Colitis 2014 ·Journal of Pediatric Gastroenterology and Nutrition ·Harland S. Winter, Piotr Krzeski, Melvin B. Heyman, (unknown), Barbara Iwańczak, M Kaczmarski, Jarosław Kierkuś, Sanja Kolaček, B. O. Osuntokun, J. Antonio Quiros, (unknown), Bruce Yacyshyn, Preston Dunnmon	10
6	Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis 2010 ·Gastroenterology ·William J. Sandborn, Joshua R. Korzenik, Bret A. Lashner, Jonathan A. Leighton, Uma Mahadevan, James F. Marion, Michael Safdi, Charles A. Sninsky, (unknown), Keith Friedenberg, Preston Dunnmon, David J. Ramsey, Sunanda V. Kane	98
7	Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial 2008 ·Journal of the American College of Cardiology ·Paul Dorian, Hussein R. Al‐Khalidi, Stefan H. Hohnloser, José M. Brum, Preston Dunnmon, Craig M. Pratt, Michael J. Holroyde, Peter R. Kowey	21
8	The Effect of Isoproterenol on the Class III Effect of Azimilide in Humans 2002 ·Journal of Cardiovascular Pharmacology and Therapeutics ·Paul Dorian, Preston Dunnmon, (unknown), David Newman	8
9	Southwestern Internal Medicine Conference: The Prevention of Congestive Heart Failure: Left Ventricular Dilation and its Management 1990 ·The American Journal of the Medical Sciences ·Brian G. Firth, Preston Dunnmon	6
10	Phorbol esters induce immediate-early genes and activate cardiac gene transcription in neonatal rat myocardial cells 1990 ·Journal of Molecular and Cellular Cardiology ·Preston Dunnmon	124
11	Left ventricular dilatation and failure post-myocardial infarction: Pathophysiology and possible pharmacologic interventions 1990 ·Cardiovascular Drugs and Therapy ·Brian G. Firth, Preston Dunnmon	6
12	Alpha 1-adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. Effects on myosin light chain-2 gene expression. 1988 ·Journal of Biological Chemistry ·(unknown), S Henderson, Robert D. Reynolds, Preston Dunnmon, D Yuan, Kenneth R. Chien	156
13	Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. 1988 ·Journal of Biological Chemistry ·A Sen, Preston Dunnmon, S Henderson, Robert D. Gerard, Kenneth R. Chien	135
14	Alpha-1 adrenergic stimulation of cardiac gene transcription in cultured neonatal rat myocardial cells: Effects on myosin light chain-2 gene expression 1987 ·Journal of Molecular and Cellular Cardiology ·Sarah B. Henderson, Preston Dunnmon, (unknown), Robyn Reynolds, (unknown), Kuo‐Liong Chien	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact